These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
267 related articles for article (PubMed ID: 36431851)
1. Strategies for Solubility and Bioavailability Enhancement and Toxicity Reduction of Norcantharidin. Liu Q; Sun H; Li X; Sheng H; Zhu L Molecules; 2022 Nov; 27(22):. PubMed ID: 36431851 [TBL] [Abstract][Full Text] [Related]
2. Review targeted drug delivery systems for norcantharidin in cancer therapy. Zhai BT; Sun J; Shi YJ; Zhang XF; Zou JB; Cheng JX; Fan Y; Guo DY; Tian H J Nanobiotechnology; 2022 Dec; 20(1):509. PubMed ID: 36463199 [TBL] [Abstract][Full Text] [Related]
3. Formulation and evaluation of norcanthridin nanoemulsions against the Plutella xylostella (Lepidotera: Plutellidae). Zeng L; Liu Y; Pan J; Liu X BMC Biotechnol; 2019 Mar; 19(1):16. PubMed ID: 30871528 [TBL] [Abstract][Full Text] [Related]
4. Norcantharidin: research advances in pharmaceutical activities and derivatives in recent years. Zhou J; Ren Y; Tan L; Song X; Wang M; Li Y; Cao Z; Guo C Biomed Pharmacother; 2020 Nov; 131():110755. PubMed ID: 33152920 [TBL] [Abstract][Full Text] [Related]
5. Cantharidin analogue alleviates dextran sulfate sodium-induced colitis in mice by inhibiting the activation of NF-κB signaling. Wu Y; Liu Z; He Z; Yi J; Qiao X; Tan C; Xing Y; Zeng Y; Yang D; Yin J; Fan B; Zeng G Eur J Med Chem; 2023 Nov; 260():115731. PubMed ID: 37643546 [TBL] [Abstract][Full Text] [Related]
6. Inhibitory effect of norcantharidin on K562 human myeloid leukemia cells in vitro. Yi SN; Wass J; Vincent P; Iland H Leuk Res; 1991; 15(10):883-6. PubMed ID: 1921448 [TBL] [Abstract][Full Text] [Related]
7. Liposomal Nanodrug Based on Norcantharidin Derivative for Increased in Vivo Activity. Kuang H; Wang P; Wang Y; Li J; Yu J; Jia L; Li S; Ma Y; Liu H; He Z; Wang Y AAPS PharmSciTech; 2023 May; 24(5):118. PubMed ID: 37165275 [TBL] [Abstract][Full Text] [Related]
8. Unique Responses of Hepatocellular Carcinoma and Cholangiocarcinoma Cell Lines toward Cantharidin and Norcantharidin. Ma Q; Feng Y; Deng K; Shao H; Sui T; Zhang X; Sun X; Jin L; Ma Z; Luo G J Cancer; 2018; 9(12):2183-2190. PubMed ID: 29937938 [TBL] [Abstract][Full Text] [Related]
9. Synthesis and anti-metastasis activities of norcantharidin-conjugated carboxymethyl chitosan as a novel drug delivery system. Chi J; Jiang Z; Qiao J; Peng Y; Liu W; Han B Carbohydr Polym; 2019 Jun; 214():80-89. PubMed ID: 30926011 [TBL] [Abstract][Full Text] [Related]
10. Supramolecular self-assembled AIE molecules are used in the search for target proteins in norcantharidin. Ma L; Sun X; Ji W; Zhang B; Li J; Fu W; Zhang X; Qian W; Sheng E; Zhu D Anal Chim Acta; 2023 Jan; 1239():340642. PubMed ID: 36628744 [TBL] [Abstract][Full Text] [Related]
11. Structural basis of serine/threonine phosphatase inhibition by the archetypal small molecules cantharidin and norcantharidin. Bertini I; Calderone V; Fragai M; Luchinat C; Talluri E J Med Chem; 2009 Aug; 52(15):4838-43. PubMed ID: 19601647 [TBL] [Abstract][Full Text] [Related]
12. Norcantharidin modulates development of dendritic cells and prolongs skin allograft survival. Hsieh CH; Liao HF; Kuo CD; Huang YC; Shueng PW; Hsu YP; Wang LY; Tsai TH; Chen YJ Transplantation; 2011 Oct; 92(8):848-57. PubMed ID: 21876479 [TBL] [Abstract][Full Text] [Related]
13. Norcantharidin induces human melanoma A375-S2 cell apoptosis through mitochondrial and caspase pathways. An WW; Wang MW; Tashiro S; Onodera S; Ikejima T J Korean Med Sci; 2004 Aug; 19(4):560-6. PubMed ID: 15308848 [TBL] [Abstract][Full Text] [Related]
14. Preparation, characterization and anticancer activity of norcantharidin-loaded poly(ethylene glycol)-poly(caprolactone) amphiphilic block copolymer micelles. Chen SF; Lu WF; Wen ZY; Li Q; Chen JH Pharmazie; 2012 Sep; 67(9):781-8. PubMed ID: 23016451 [TBL] [Abstract][Full Text] [Related]
15. Mechanisms of norcantharidin against renal tubulointerstitial fibrosis. Yun QS; Bao YX; Jiang JB; Guo Q Pharmacol Rep; 2024 Apr; 76(2):263-272. PubMed ID: 38472637 [TBL] [Abstract][Full Text] [Related]
16. Inhibitory effect of norcantharidin on the growth of human gallbladder carcinoma GBC-SD cells in vitro. Fan YZ; Fu JY; Zhao ZM; Chen CQ Hepatobiliary Pancreat Dis Int; 2007 Feb; 6(1):72-80. PubMed ID: 17287171 [TBL] [Abstract][Full Text] [Related]
17. Synthesis and in vitro cellular evaluation of novel anti-tumor norcantharidin-conjugated chitosan derivatives. Xu X; Li Y; Shen Y; Guo S Int J Biol Macromol; 2013 Nov; 62():418-25. PubMed ID: 24099934 [TBL] [Abstract][Full Text] [Related]
18. Primary in vitro and in vivo evaluation of norcantharidin-chitosan/poly (vinyl alcohol) for cancer treatment. Li M; Xu X; Lu F; Guo S Drug Deliv; 2014 Jun; 21(4):293-301. PubMed ID: 24156408 [TBL] [Abstract][Full Text] [Related]
19. Folate receptor-targeted liposomes loaded with a diacid metabolite of norcantharidin enhance antitumor potency for H22 hepatocellular carcinoma both in vitro and in vivo. Liu MC; Liu L; Wang XR; Shuai WP; Hu Y; Han M; Gao JQ Int J Nanomedicine; 2016; 11():1395-412. PubMed ID: 27110110 [TBL] [Abstract][Full Text] [Related]
20. Liquid chromatography-tandem mass spectrometry evaluation of the pharmacokinetics of a diacid metabolite of norcantharidin loaded in folic acid-targeted liposomes in mice. Liu MC; Ma XQ; Xu Y; Peng LH; Han M; Gao JQ J Pharm Biomed Anal; 2016 Feb; 119():76-83. PubMed ID: 26658337 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]